Article may be outdated

This article is 12 days old. Some details may have changed since publication.

Headlinne
Sign inGet Headlinne
Nature·4 min read·hard

In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer

G
Galal, Soaad
In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer
✦AI Summary

Researchers have utilized in vivo CRISPR/Cas9 screening to identify specific genes that act as metastasis suppressors in triple-negative breast cancer. The study highlights how the loss of these genes promotes tumor progression and suggests potential targets for future therapeutic intervention.

Why it mattersUnlock →

Nature Communications ( 2026 ) Cite this article

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth
Political bias analysisUnlock →
Read originalGet full access
✦

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in